X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

NEUROPSYCHOPHARMACOLOGY

期刊標題檢索 NEUROPSYCHOPHAR 最新評論: Focused research direction: sharing experiences in the field of mental... (2024-05-27)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[NEUROPSYCHOPHARMACOLOGY]您好,您是該頁面的第 63057 位訪客。

期刊簡介
期刊名稱NEUROPSYCHOPHARMACOLOGY NEUROPSYCHOPHARMACOLOGY
LetPub Score
8.7
50 ratings
Rate

Reputation
10.0

Influence
8.1

Speed
7.0

期刊簡稱NEUROPSYCHOPHARMACOL
ISSN0893-133X
E-ISSN1740-634X
h-index204
CiteScore
CiteScoreSJRSNIPCiteScore Rank
15.002.7431.871
Subject fieldQuartilesRankPercentile
Category: Medicine
Subcategory: Psychiatry and Mental Health
Q119 / 567
Category: Medicine
Subcategory: Pharmacology
Q116 / 313

自引率 (2023-2024)1.50%自引率趨勢
掲載範囲
Neuropsychopharmacology is an international scientific journal and the official publication of the American College of Neuropsychopharmacology. The journal focuses on clinical and basic science contributions that advance our understanding of the brain and behavior.
官方網站https://www.nature.com/npp
在線稿件提交https://mts-npp.nature.com/
開放訪問No
出版商Springer Nature
主題領域医学
出版國/地區ENGLAND
發行頻率月刊
創刊年1993
每年文章數175每年文章數趨勢
黃金OA百分比35.81%
Web of Science 四分位
2023-2024
WOS Quartile: Q1

CategoryEditionJIF QuartileJIF RankingJIF Percentage
NEUROSCIENCESSCIEQ129/310
PHARMACOLOGY & PHARMACYSCIEQ120/354
PSYCHIATRYSCIEQ117/276
索引 (SCI or SCIE)Science Citation Index
Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=0893-133X%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: Average 2 Month(s)
競爭力 *來自作者的數據: About 28.75%
參考鏈接
相關期刊 【NEUROPSYCHOPHARMACOLOGY】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    World PsychiatryH-index: 70

    CiteScore: 64.10
    PSYCHOTHERAPY AND PSYCHOSOMATICSH-index: 86

    CiteScore: 29.40
    AMERICAN JOURNAL OF PSYCHIATRYH-index: 325

    CiteScore: 22.30
    Biological PsychiatryH-index: 290

    CiteScore: 18.80
    MOLECULAR PSYCHIATRYH-index: 196

    CiteScore: 20.50
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRYH-index: 222

    CiteScore: 21.00
    BRITISH JOURNAL OF PSYCHIATRYH-index: 209

    CiteScore: 13.70
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRYH-index: 188

    CiteScore: 15.70
    CURRENT OPINION IN PSYCHIATRYH-index: 80

    CiteScore: 12.20
    CNS DRUGSH-index: 100

    CiteScore: 12.00
    學科內最受檢索的期刊 頁面查看次數
    JOURNAL OF AFFECTIVE DISORDERS153847
    MOLECULAR PSYCHIATRY83378
    PSYCHIATRY RESEARCH69279
    Biological Psychiatry68548
    BMC Psychiatry59555
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY48031
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY46023
    JOURNAL OF PSYCHIATRIC RESEARCH45692
    PSYCHOLOGICAL MEDICINE43346
    ADDICTION41665
  •  

    NEUROPSYCHOPHARMACOLOGY NEUROPSYCHOPHARMACOLOGY
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    下一頁    末頁  (頁
/1)
  [NEUROPSYCHOPHARMACOLOGY] 的評論撰寫評論
作者: 璃月琦巧


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-05-27 21:05:10 評論於
Focused research direction: sharing experiences in the field of mental health: submitted
(0) 讚! | 璃月琦巧

作者: 润宾来了


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-04-27 10:00:01 評論於
Hello, just wanted to ask how long have you been using it. I am currently waiting for the proof as well
(0) 讚! | 润宾来了

作者: yuyuyu111


領域: 医学
審稿時間: 2.0 month(s)
結果: 修改後接受


撰寫評論

2023-07-16 13:44:07 評論於
Revision Received 19th May 23 (Revised once)
Waiting for Revision 4th Apr 23
Decision Made 4th Apr 23
Under Review 21st Feb 23
Submission 12th Feb 23

Revision Received 7th Jul 23 (Revised once)
Waiting for Revision 3rd Jul 23
Decision Made 3rd Jul 23
Under Review 13th Jun 23
Submission 11th Jun 23
Manuscript Deleted 19th May 23
Submission 19th May 23

Revision Received 10th Jul 23 (Revised twice)
Post Decision 10th Jul 23
Under Review 7th Jul 23
Submission 7th Jul 23
Successfully Received
(0) 讚! | yuyuyu111

作者: 东霞mio


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-06-19 20:08:52 評論於
How long does it usually take for something to be under review?
(0) 讚! | 东霞mio

作者: 东霞mio


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-06-19 19:45:24 評論於
It has been half a month since I submitted, but I haven't received any news. May I ask if I should continue waiting?
(0) 讚! | 东霞mio

作者: 东霞mio


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-06-19 15:33:27 評論於
It has been half a month since the submission was made, and there is still no news. Can my colleagues give some suggestions on whether this is a polite rejection? Is it necessary to continue waiting?
(0) 讚! | 东霞mio

作者: 八荒建玲


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-01-29 18:23:15 評論於
Excuse me, what does this status indicate? How long did it take for you to submit it for review later?
(0) 讚! | 八荒建玲

作者: 八荒建玲


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-01-29 08:25:21 評論於
How long did you submit it for review later?
(0) 讚! | 八荒建玲

作者: 华清柔怀


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-09-25 11:57:10 評論於
How long does it take to receive the proof email after accepting?
(0) 讚! | 华清柔怀

作者: 曼雁小娘子


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-06-29 13:35:42 評論於
Do you require full membranes for Western blot in this journal?
(0) 讚! | 曼雁小娘子

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 23:17:11 評論於
There is no fixed requirement for the discussion, so feel free to write it based on your own situation
(0) 讚! | 维尔娜菲茨杰拉德

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 11:45:23 評論於
Contrary to the introduction which is typically structured like an inverted pyramid, the discussion section expands from small to large in a funnel shape. Starting from the rationale of each research result, anomalies, and underlying principles, a detailed analysis is gradually conducted. After laying the groundwork, the main conclusions of the paper can be naturally introduced for discussion, followed by further expansion to point out the importance/significance/generality/application value of the research
(0) 讚! | 维尔娜菲茨杰拉德

作者: 上清雨真


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-28 19:57:51 評論於
How many paragraphs should a discussion generally be divided into?
(0) 讚! | 上清雨真

作者: 深渊兴业


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-27 16:12:53 評論於
What is the difference between an introduction and a discussion?
(0) 讚! | 深渊兴业

作者: 东风太枝


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-05-08 09:26:44 評論於
It has been 11 days since submission. How much longer until it is sent for review?
(0) 讚! | 东风太枝

作者: 玄虚琛丽


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-05-05 16:37:07 評論於
What original data do we need to prepare?
(0) 讚! | 玄虚琛丽

作者: 凌霄温韦


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2018-09-03 23:45:20 評論於
Can you provide the PMID for this? I want to learn more
(0) 讚! | 凌霄温韦

作者: 一只安娴呀


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2017-10-24 17:19:02 評論於
Review speed: 2.0 | Submission success rate: 50.0 Experience sharing: Compound Chinese medicine preparation
(0) 讚! | 一只安娴呀

作者: 运凯小可爱


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2017-09-30 11:16:02 評論於
I don't know what to do
(0) 讚! | 运凯小可爱

作者: 凌霄高洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2012-12-26 16:50:23 評論於
Review speed: 2.0 | Submission acceptance rate: 5.0
Experience sharing: The first review of our submission took 52 days, and it took 35 days for the second review after major revisions. Now the editor-in-chief asked for minor revisions without an external review. This journal is quite good. Several reviewers are experts in the field, and the questions they raise are very professional. I have benefited a lot
(0) 讚! | 凌霄高洁

作者: 凌霄高洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2011-11-15 18:48:36 評論於
Review speed: 3.0 | Submission hit rate: 5.0
Experience sharing: Several departments in our school have submitted over 20 articles, but only one has been accepted. It's very difficult!
(0) 讚! | 凌霄高洁

作者: 凌霄高洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2011-11-06 21:36:08 評論於
Review Speed: 1.0 | Submission Success Rate: 5.0
Experience Sharing: A streak of hitting the mark on the first try, getting three in a row, it's like playing a game. Definitely lucky, or just plain stupid. It's really difficult, unless you know someone, or have a lot of colorful pictures
(0) 讚! | 凌霄高洁

作者: 凌霄高洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2011-06-10 21:37:54 評論於
Review speed: 2.0 | Submission success rate: 75.0 Experience sharing: I have hit three papers above, which is relatively easy, you can come here to play casually
(0) 讚! | 凌霄高洁

作者: 凌波安兴


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2011-04-14 16:47:27 評論於
It doesn't seem too difficult to find references for it, the required amount of data is not very large, as long as you refine it and have innovation, it shouldn't be difficult
(0) 讚! | 凌波安兴

作者: 凌霄高洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2011-01-05 10:48:37 評論於
Under review for 12 days, then rejected. The reviewers for the journal are all highly respected experts, and their questions are challenging and very professional
(0) 讚! | 凌霄高洁

首頁    上一頁    1    下一頁    末頁  (頁
/1)

開始撰寫 [NEUROPSYCHOPHARMACOLOGY] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*